Physician profile
Joseph Patrick Iannotti
NPI 1306809306
$7,052,452.13
in general payments reported to CMS, 2019-2025
13 companies · $1.0M in 2025
The $1.0M reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.3M · 2020: $1.0M · 2021: $958K · 2022: $994K · 2023: $992K · 2024: $818K · 2025: $1.0M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.4M · Consulting Fee: $391K · Travel and Lodging: $19K · Food and Beverage: $2,443.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,416,428.26 |
| Consulting Fee | $390,950.00 |
| Travel and Lodging | $18,528.76 |
| Food and Beverage | $2,443.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Encore Medical, Lp | $4,856,764.00 | 2019-2025 | Djo Surgical |
| Depuy Synthes Products, INC. | $1,770,850.21 | 2019-2025 | Global |
| Arthrex, INC. | $375,032.00 | 2019-2021 | |
| Insight Medical Systems, INC. | $44,024.70 | 2023-2024 | Arvis |
| Wright Medical Technology, INC. | $5,101.20 | 2019-2020 | |
| Catalyst Orthoscience | $127.79 | 2024 | Catalyst Csr Shoulder System, R1 Reverse Shoulder System |
| Depuy Synthes Sales INC. | $124.99 | 2024 | Inhance |
| Medacta USA, INC. | $117.00 | 2022 | |
| Medical Device Business Services, INC. | $106.23 | 2022 | |
| Stryker Corporation | $100.05 | 2021 | |
| Zimmer Biomet Holdings, INC. | $43.66 | 2025 | Gel-One Cross-Linked Hyaluronate |
| Fx Shoulder Solutions, INC | $35.34 | 2020 | |
| Smith+Nephew, INC. | $24.96 | 2024 | Pico 14 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Iannotti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.